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Detection of rhinovirus-associated asthma exacerbations using reverse transcriptase-
polymerase chain reaction in Egyptian children 
 
INTRODUCTION 
Acute asthma exacerbation is a cause of strong 
concern among children and parents and represents 
a challenge for pediatric healthcare providers1. 
Studies reported the issue of “virus-induced 
exacerbation in asthma and chronic obstructive 
pulmonary disease” and evidence of viral infection 
is found in 80% to 90% of childhood wheezing 
episodes2,3. More than 200 different types of 
viruses, such as human rhinovirus (HRV), human 
metapneumovirus (HMPV), respiratory syncytial 
virus (RSV), and human parainfluenza virus 
(HPIV) are known to cause acute respiratory 
illness4. However, among these causative viruses, 
HRV is now recognized to have a major impact on 
asthma pathogenesis5,6. Rhinovirus (genus 
Enterovirus, family Picornaviridae), a virus of 
considerable heterogeneity comprising over 100 
serotypes, is the main cause of common cold and is 
consistently associated with sudden-onset asthma 
attacks in children and adults7. Typically, HRVs are 
segregated into two groups, HRV-A and HRV-B, 
although a new potentially more virulent and 
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exacerbation-relevant group (HRV-C) has recently 
been identified8. HRVs are predominant during the 
spring and autumn. They have been incriminated 
for the peak in pediatric asthma exacerbations at 
this time of year termed the September epidemic9. 
The definitive diagnosis of respiratory viral 
infections is complicated by the lack of commercial 
availability of a rapid and cost-effective laboratory 
test to confirm the presence of viral respiratory 
infections10. The gold standard laboratory 
requirement for the culture confirmation of viral 
infection was difficult to apply, had low sensitivity, 
and resulted in underdetection of viral infections11. 
The rhinovirus and coronavirus were difficult to 
culture, and convalescent serology was often not 
available. The recent increasing use of PCR 
amplification methods in studies of respiratory 
viruses (in particular the rhinovirus) has provided 
new information on viral epidemiology and has 
contributed to the understanding of the role of 
viruses in exacerbations of asthma12. Furthermore, 
the use of induced sputum samples, obtained non-
invasively, facilitates viral detection, because 
induced sputum (RT-PCR) has been found to be a 
more sensitive and rapid diagnostic method than 
conventional serology and immunofluorescence13. 
This study aimed to detect HRV-induced asthma 
exacerbations (including the new HRV-C genotype) 
in a group of Egyptian children.  
 
METHODS 
This cross-sectional study was conducted on 31 
asthmatic children in exacerbations in the period 
from September 2014 till October 2015. Patients 
were recruited from the emergency department and 
chest clinic, Children's hospital, Ain Shams 
University. An informed consent was obtained from 
the parents or caregivers before enrollment. The 
study protocol was approved by the ethics 
committee of the Pediatric department, Ain Shams 
University. 
Detailed history was taken stressing on 
residence, history of atopy (atopic dermatitis and 
allergic rhinitis) and family history of asthma. 
Patients with comorbid illnesses or those suffering 
from any other broncho-pulmonary diseases were 
excluded from the study. The age of the studied 
patients was categorized according to Eunice 
Kennedy Shriver National Institute of Child Health 
and Human Development in the United States 
(2011).  
Full clinical examination was done and the 
severity of exacerbations was classified according 
to GINA, 2015 into mild- moderate, severe and life 
threatening. The criteria for exacerbation severity 
were based on symptoms, parameters of physical 
examination and oxygen saturations. 
RT-PCR test was done to detect HRV in sputum 
samples (children ≥7years) and nasopharyngeal 
aspirates (infants and children<7years) and 
according to the results, the studied population were 
classified into HRV negative and positive groups. 
 
Sample preparation 
Each sample was mixed in the mucous collector 
with 2 ml of virus transport media and votexed and 
transferred to 2 tubes each 1.5 ml, one tube used for 
RNA extraction and the second was frozen as back 
up. Total sample RNA extraction was done using 
QIAgen viral RNA Kit® (QIAgen, Germany). The 
preparation of kit reagents and RNA extraction 
were done according to the manufacturer’s 
instruction. 
 
One-Step, Real-Time PCR Assay 
In this one-step, real-time PCR assay, reverse 
transcription and PCR amplification were 
performed in the same reaction tube. The total 
reaction volume was 50 µl, and the reaction mixture 
contained 0.9 µmol/L (each) of the primers, 0.15 
µmol/L of the probe, TaqMan One Step PCR 
Master Mix Reagents kit (Applied Biosystems) 
components, and 5 µl of extracted sample. The 
primers and TaqMan probe used had the following 
sequence14: primer Pic-1 (positions 377 to 393), 5’-
TCCTCCGGCCCCTGAAT-3’  (melting 
temperature of 59.9°C); Pic-3 (positions 496 to 
474), 5’-GAAACACGGACACCCAAAGTAGT- 
3’ (melting temperature of 58.1°C); and probe Pic-5 
(positions 395 to 410), Fam 5’-
YGGCTAACCYWAACCC-3’ (melting 
temperature of 68.8°C to 76.8°C). All sample 
lysates and controls, were tested in duplicate 
reactions. The thermal cycling program consisted of 
48°C for 30 minutes, 95°C for 10 minutes, and 45 
two-step cycles of 95°C for 15 seconds and 60°C 
for 1 minute, and was conducted by using the Step 
One Sequence Detection System (Applied 
Biosystems). Each run included the testing of the 
positive and negative extraction control lysates, 
Tris-EDTA buffer in four reactions (no template 
controls), and diethylpyrocarbonate-treated water 
(QIAgen, Germany) in duplicate reactions for each 
set of five specimen lysates (negative reagent 
controls). The no template controls and negative 
reagent controls were used to detect any nonspecific 
fluorescent signal or carry-over contamination. Run 
acceptability required obtaining the expected results 
from each control. The total run time for this 
protocol was 2.5 hours. Samples were considered 
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positive if the amplification plots (i.e., change in 
normalized reporter signal [delta Rn] versus PCR 
cycle number) from duplicate reactions showed 
definite exponential increase in fluorescent signal 
(Figure 1). 
 
Rhinovirus C specific conventional RT-PCR 
One step RT-PCR was used to detect Rhinovirus C 
among positive cases detected by pan-Rhino real 
time PCR. Two primers were used FC and RC 
which are specific for rhino viruses C15. The Test 
was done using QIAgen one step RT-PCR kit 
(QIAgen, Germany) in 50 µl volumes as described 
by the manufacturer. The cycling parameters were 
initial RT step at 50oC for 30 minutes followed by 
hot start enzyme activation at 95oC for 15 minutes 
followed by 40 cycles each of 94 OC for 45 seconds, 
annealing at 55oC for 45 seconds and extension at 
72oC for 1 minute. PCR product was detected by 
Gel electrophoresis with specific product at 330 
base pairs (Figure 2).  
 
Statistical analysis 
Data was analyzed using the Statistical Program for 
Social Science (SPSS) version 18.0. Quantitative 
data was expressed as mean± standard deviation 
(SD). Qualitative data was expressed as frequency 
and percentage. Chi-square (X2) test was used to 
compare the proportions between two qualitative 
parameters. Independent-samples t-test was used to 




This study included 31 asthmatic children. They 
were 15 males (48.4%) and 16 females (51.6%) 
presented with acute asthma exacerbations. Their 
ages ranged from 7 months to 12 years with a mean 
and SD of (4.47 ± 3.15) years. Eight (25.8%) of the 
total population showed positive Rhinovirus RT-
PCR. Four (12.9%) of   the total population (50% of 
the RV positive patients) were of the Rhinovirus C 
group. 
Analysis of demographic data of the studied 
population showed no statistically significant 
differences between HRV negative and positive 
groups as regards to age, sex, seasonal distribution 
and history of atopy but HRV positive patients 
showed a statistically significant higher percentage 
of positive family history of bronchial asthma when 
compared to the HRV negative patients (Table 1). 
All HRV positive patients required hospital 
admission, 7(87.5%) in the ward and one (12.5%) 
died in the pediatric intensive care (PICU), while 
15(65.2%) of the HRV negative group required 
admission in the ward and no one was admitted in 
the PICU. There was a statistically significant 
difference between both groups as regards to the 
outcome (X 2= 6.073, p=0.048). 
Characteristics of HRV-C positive patients: 
Of the total population, 4 had RV-C infection (2 
toddlers and 2 preschoolers). All had life-
threatening exacerbations. One was complicated by 
acute pneumonia and died in PICU. All cases were 
detected in winter and all had a positive family 
history of bronchial asthma. However, statistical 
comparison   between the   HRV-C positive patients 
and those with other types was non-applicable due 















Table 1. Comparison between HRV negative and positive groups as regards to Demographic data 
 
  Pan Rhinovirus Real time PCR Chi-square test 
No. Negative(n=23) Positive(n=8) X2 P-value 
Age group 
(years) 
Infant 7 5 (21.7%) 2 (25%) 
1.037 0.792 
Toddler 6 5 (21.7%) 1 (12.5%) 
school age 10 8 (34.8%) 2 (25%) 
Preschool 8 5 (21.7%) 3 (37.5%) 
Mean ± SD  4.78 ± 3.42 3.60 ± 2.17 
0.908 0.372 
Range  0.6- 12 0.9- 6 
Gender 
Female 16 12 (52.2%) 4 (50%) 
0.011 0.916 
Male 15 11 (47.8%) 4 (50%) 
Seasonal distribution 
Early fall 4 3 (13%) 1 (12.5%) 
0.002 0.968 
Winter 27 20 (87%) 7 (87.5%) 




2 (8.7%) 2 (25%) 
3.394 0.183 
Allergic rhinitis 6 6 (26.1%) - 
Negative 21 15 (65.2%) 6 (75%) 
Family history of Bronchial 
asthma 
Negative 18 17 (73.9%) 1 (12.5%) 
9.194 0.002* 
Positive 13 6 (26.1%) 7 (87.5%) 
 
 
Table 2. Comparison between HRV negative and positive groups as regards to the respiratory manifestations 
 
  Pan Rhinovirus Real time RT-PCR Chi-square test 
 Negative (n=23) Positive (n=8) X2 P-value 
Cough 
Positive  21(91.3%) 8(100%) 
0.744 0.389 
Negative  2 (8.7%) - 
Dyspnea 
At rest  9 (39.1%) 7 (87.5%) 
5.56 0.018* 
On exertion  14 (60.9%) 1 (12.5%) 
Alertness 
Agitated  12 (52.2%) 8 (100%) 
5.930 0.015* 
Calm  11 (47.8%) - 
Wheeze on 
Auscultation 
Loud inspiration and expiration  1 (4.3%) 7 (87.5%) 
21.953 0.000* Loud in expiration only  16 (69.6%) - 
Moderate  6 (26.1%) 1 (12.5%) 
             
DISCUSSION 
Respiratory viruses are the most common triggers 
of exacerbations, accounting for approximately 
85% of cases, and HRV represents the great 
majority of viruses detected16. The presentation of 
children with infection-induced wheezing is 
influenced by age, previous respiratory infections, 
genetic background, and sensitization to 
aeroallergens, environmental influences and 
interactions between these factors17. 
The advent of molecular viral diagnostics has 
expanded our understanding of the epidemiology of 
respiratory illnesses in infancy by improved 
detection rates for known viruses, and surprisingly, 
has led to the discovery of previously unrecognized 
respiratory viruses. These new diagnostic 
techniques have been particularly helpful in 
understanding the role of HRV, which are 
particularly difficult to grow in tissue culture, in 
acute illness and asthma exacerbations18. 
With this background, this study aimed to detect 
HRV- induced asthma exacerbations in a group of 
Egyptian children and to determine the presence of 
HRV- C genotype among them.  
This cross-sectional study was conducted on 31 
asthmatic children in exacerbations in the period 
from September 2014 till October 2015. Patients 
were recruited from the emergency department and 
chest clinic, Children's hospital, Ain Shams 
University. They were 15 males (48.4%) and 16 
females (51.6%). Their ages ranged from 7 months 
to 12 years with a mean and SD of (4.47 ± 3.15) 
years.  
Rhinovirus-associated asthma exacerbations 
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It was estimated that approximately two-thirds 
of infections associated with asthma exacerbations 
were caused by HRV19. In this study, eight (25.8%) 
out of 31 patients showed positive Rhinovirus RT-
PCR test.  Four out of 31 (12.9%) were of the 
Rhinovirus C genotype (50% of HRV positive 
cases). In agreement with this study, Lau et al.20 
detected HRVs in 178 (29.7%) of 600 NPAs taken 
from children. Of them, HRV-C was found in 
78(13%) of   patients (43.8% of HRVs). Venarske 
et al.21 conducted a cohort study of 101 asthmatic 
patients during 1999–2003, enrolled at hospital 
admission for an asthma exacerbation and   found 
that HRV was detected by RT-PCR in 21% of 
hospitalized patients over a 4-year period. 
Furthermore, Louie et al.22 studied 43 children 
admitted to the intensive care unit due to asthma 
exacerbation and detected HRV in 21(48.8%) of 
them. Also, Lau et al.8 found HRV-C among 21 
(10.3%) of 203 NPAs from children hospitalized 
for acute respiratory illness. Moreover, Arden et 
al.23 detected HRV in 41(52.6%) of 78 NPAs of 
children with asthma exacerbation not requiring 
admission to hospital. They found that HRV-Cs 
were the viruses most frequently detected as single 
virus detection in 23(29.5%) of the total population 
(56.1% of HRVs). 
Although rhinoviruses are the most perennial of 
the respiratory viruses, with transmission in all 
months of the year, peaks of RV illness have been 
well –documented in September, after school opens 
and again in the spring24. In this study, most 
(87.1%) of the total population were collected in 
winter with no significant difference between both 
groups. This can be attributed to other respiratory 
viruses that could have been involved among the 
HRV negative group such as Respiratory syncytial 
virus (RSV) and influenza. RSV and influenza have 
been associated with increased asthma 
exacerbations during winter months25. Moreover, 
Arden et al.26 found that HRV detections were made 
in every season while, Piotrowska et al.27 reported 
that HRV-C induced asthma exacerbation can 
happen all over the year, without peaks in the 
spring and fall. Also, Lau et al.20 found that a 
diverse set of HRV-C genotypes was circulating 
throughout the year. This variation underscores the 
importance of studies over multiple years and 
seasons to understand fully the geographical and 
seasonal rhinovirus epidemiology and its role in 
asthma exacerbation28. 
A positive family is a known risk factor for 
asthma development, and it has recently been found 
that infants of mothers with asthma are more likely 
to have severe respiratory tract infections with 
HRV29. In this study, HRV positive patients showed 
a statistically significant higher percentage of 
positive family history of bronchial asthma when 
compared to HRV negative patients. In accordance 
with this study, the Tennessee Children’s 
Respiratory Initiative reported that having a mother 
with atopic asthma significantly increased the risk 
of the infant experiencing HRV infection compared 
with RSV infection. Interestingly, maternal asthma 
increased the severity of infant HRV infection but 
not that of RSV infection. Thus, compared with 
infants with RSV infection, infants with HRV 
infections are more likely to have an atopic 
predisposition reflected by positive family history. 
These findings suggest that there is likely an 
underlying genetic basis for risk of and response to 
respiratory infections30.  
The relative importance and disease severity 
associated with the two-pre-existing species, HRV-
A and HRV-B and the newly described species, 
HRV-C are not well understood20. Recent reports 
have implicated HRVs in more severe upper and 
lower respiratory tract infections, especially in 
children31. In this study, HRV positive patients 
showed   statistically significant higher percentage 
of dyspnea, agitation, distress and desaturations. 
Comparatively, they showed   statistically 
significant higher percentage of life-threatening   
exacerbations   and thus   hospitalization   and no 
one experienced mild to moderate   degree of 
exacerbation although, the higher proportion of life-
threating cases may be an overestimate as this is a 
tertiary hospital- based study to which the severe 
and life threatening cases are referred to. In 
agreement with our results, Venarske et al 21 found 
that HRV detection was strongly associated with 
hospitalization for asthma and HRV positive 
patients were more severe than HRV negative 
patients.  
Unfortunately, in other studies that described the 
detection of HRV-A and HRV-B in addition to the 
new genotypes, the results were often limited by 
either the small number of samples with positive 
results or a lack of clinical and epidemiological 
data32.  Further clinical studies that involve more 
patients with HRV infection are required to 
investigate whether certain HRV species or strains 
may be more virulent than others20. In this study, 
All HRV-C patients were hospitalized for life-
threatening exacerbations. Unfortunately, no 
systematic study has been carried out to examine 
the epidemiology and clinical features of HRV-C, 
compared with those of HRV-A and HRV-B as 
most of the performed studies only focused on the 
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molecular identification of HRV-C from clinical 
samples20.  
Finally, the population’s characteristics and our 
diagnostic methods may explain the slight 
variations to other investigators as we included only 
children with a previous diagnosis of asthma and 
excluded patients with comorbid illnesses, patients 
on systemic steroids   and those suffering from 
other broncho-pulmonary diseases such as 
bronchiectasis and pneumonia, while other studies 
of hospitalized children enrolled all children with 
wheezing including bronchiolitis and pneumonia. 
Limitations of this work were the absence of 
detection of other viruses precipitating 
exacerbations of bronchial asthma for comparison 
and the relatively small sample size.  
 
CONCLUSION 
HRVs are important triggers of asthma 
exacerbations among Egyptian children. The newly 
described HRV-C genotype accounts for a 
significant proportion of HRV- associated asthma 
exacerbations. Further studies on a larger scale are 
needed for HRV-C and other possibly undiscovered 
HRV genotypes that may help future attempts to 
produce a protective pan-serotype human 
Rhinovirus vaccine with possible cross-serotype 
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